Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Favorable safety and lipid profiles with anacetrapib therapy in hyperlipidemia

Nov. 19, 2009

E-3810 exhibits potent antiangiogenic activity in preclinical studies

Nov. 19, 2009

CH-5137291evaluated in preclinical models of castration-resistant prostate cancer

Nov. 19, 2009

Phase I data on JNJ-26483327 in solid tumors reported at 2009 AACR-NCI-EORTC meeting

Nov. 18, 2009

Clinical data presented from 3 trials on sorafenib for HCC therapy

Nov. 18, 2009

Rifaximin exhibits durable long-term protection in hepatic encephalopathy trial

Nov. 18, 2009

Clinical data reported for boceprevir plus PegIntron/ribavirin in HCV

Nov. 18, 2009

Data from phase III trials support safety and efficacy of tenofovir DF in CHB patients

Nov. 18, 2009

SB-939 shows favorable PK, PD and safety in phase I trial in advanced solid tumors

Nov. 17, 2009

IMO-2125 shows promising anti-HCV activity in preclinical evaluation

Nov. 17, 2009

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...